Jiang-Ping Wu

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 123(Granted Patents)

Company Filing History:

10 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

3 out of 1,535

Boehringer Ingelheim International Gmbh

patents

Years Active: 2002-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8946203 - Benzodioxane inhibitors of leukotriene production (2015-02-03),

2. 8859814 - [object Object] (2014-10-14),

3. 8299123 - CCR10 antagonists (2012-10-30),

4. 7550494 - Small molecules useful in the treatment of inflammatory disease (2009-06-23),

5. 7470692 - Cytokine inhibitors (2008-12-30),

6. 7405225 - Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2008-07-29),

7. 6974870 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-12-13),

8. 6964956 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-11-15),

9. 6689804 - Small molecules useful in the treatment of inflammatory disease (2004-02-10),

10. 6492408 - Small molecules useful in the treatment of inflammatory disease (2002-12-10),

11. 6414153 - 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease (2002-07-02),

12. 6365615 - Small molecules useful in the treatment of inflammatory disease (2002-04-02),

13. 6355664 - Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease (2002-03-12),

Certainly! Here is an article about inventor Jiang-Ping Wu:

Title: Unveiling the Pioneering Work of Inventor Jiang-Ping Wu

Introduction:

Jiang-Ping Wu, a distinguished inventor based in Danbury, CT, has made significant contributions to the field of pharmaceuticals with a total of 13 patents under his name. His innovative approach and groundbreaking inventions have revolutionized the treatment of various diseases and disorders.

Latest Patents:

Among his latest patents is the development of Benzodioxane inhibitors of leukotriene production. These compounds, meticulously formulated as per formula (I), have shown promising results as inhibitors of leukotriene Ahydrolase (LTA4H) and in treating LTA4H related disorders. Additionally, Jiang-Ping Wu has also introduced a novel compound to address disorders associated with the activation of CCR10, further enhancing the pharmaceutical landscape.

Career Highlights:

Jiang-Ping Wu has garnered extensive experience and expertise through his tenure at renowned companies such as Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. His dedication to research and development has led to the successful implementation of innovative solutions in the medical domain, positioning him as a prominent figure in the industry.

Collaborations:

Throughout his career, Jiang-Ping Wu has collaborated with esteemed professionals in the field, including Terence Alfred Kelly and Ronald John Sorcek. These collaborations have not only enriched his work but have also resulted in the creation of groundbreaking technologies that continue to shape the future of pharmaceutical advancements.

Conclusion:

In conclusion, Jiang-Ping Wu's inventive spirit and commitment to excellence have propelled him to the forefront of pharmaceutical innovation. His remarkable patents and strategic collaborations underscore his passion for advancing medical science and improving the quality of life for individuals worldwide. Jiang-Ping Wu stands as a beacon of inspiration for aspiring inventors and a driving force behind the transformative changes in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.